CAS 847499-27-8 appears in our catalog under these names: Delanzomib, Delanzomib/ 99.46% (existing batch purity), CEP–18770, Delanzomib [CEP-18770], Delanzomib 98%. Offered by: TRC, TargetMol, GLPBio, Chemat, Ambeed. Available pack sizes: 50mg, 1mg, 2mg, 5mg, 10mg, 25mg, 100mg, 10mM (in 1ml dmso).
Delanzomib is a C-terminal boronic acid peptide inhibitor which induces apoptosis in multiple myeloma, hematological and solid tumor cell lines. It has a role as an antineoplastic agent, a proteasome inhibitor and an apoptosis inducer. It is a C-terminal boronic acid peptide, a threonine derivative, a secondary alcohol and a phenylpyridine. It is functionally related to a L-threonine.
Source: ChEBI
| Molecular formula | C21H28BN3O5 |
|---|---|
| Molecular weight | 413.3 g/mol |
| IUPAC name | [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid |
| InChIKey | SJFBTAPEPRWNKH-CCKFTAQKSA-N |
| SMILES | B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O |
Computed by PubChem (NCBI)